Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Johanna, Berkhout"'
Autor:
Johanna, Berkhout, Maria J, Melchers, Anita C, van Mil, Claudia M, Lagarde, Wright W, Nichols, Johan W, Mouton
Publikováno v:
Journal of chemotherapy (Florence, Italy). 33(6)
The post-antibiotic effect (PAE) of ceftazidime-avibactam
Autor:
Anita C. van Mil, Johanna Berkhout, Claudia M. Lagarde, Wright W. Nichols, Seyedmojtaba Seyedmousavi, Johan W. Mouton, Maria J. Melchers
Publikováno v:
Antimicrobial Agents and Chemotherapy, 59, 4, pp. 2299-304
Antimicrobial Agents and Chemotherapy, 59, 2299-304
Antimicrobial Agents & Chemotherapy, 59(4), 2299-2304. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 59, 2299-304
Antimicrobial Agents & Chemotherapy, 59(4), 2299-2304. American Society for Microbiology
Ceftazidime and the β-lactamase inhibitor avibactam constitute a new, potentially highly active combination in the battle against extended-spectrum-β-lactamase (ESBL)-producing bacteria. To determine possible clinical use, it is important to know t
Autor:
Virna J A Schuck, Wright W. Nichols, Johan W. Mouton, Seyedmojtaba Seyedmousavi, Anita C. van Mil, Maria J. Melchers, Claudia M. Lagarde, Johanna Berkhout
Publikováno v:
Antimicrobial Agents and Chemotherapy, 60, 1, pp. 368-75
Antimicrobial Agents & Chemotherapy, 60(1), 368-375. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 60, 368-75
Antimicrobial Agents & Chemotherapy, 60(1), 368-375. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 60, 368-75
Avibactam is a new non-β-lactam β-lactamase inhibitor that shows promising restoration of ceftazidime activity against microorganisms producing Ambler class A extended-spectrum β-lactamases (ESBLs) and carbapenemases such as KPCs, class C β-lacta
Publikováno v:
Antimicrobial Agents and Chemotherapy, 59, 1138-44
Antimicrobial Agents and Chemotherapy, 59, 2, pp. 1138-44
Antimicrobial Agents & Chemotherapy, 59(2), 1138-1144. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 59, 2, pp. 1138-44
Antimicrobial Agents & Chemotherapy, 59(2), 1138-1144. American Society for Microbiology
To evaluate the in vitro effects of the combination of ceftazidime and avibactam on the MICs of both compounds, checkerboard assays were performed for 81 clinical strains, including 55 Enterobacteriaceae strains (32 Klebsiella pneumoniae , 19 Escheri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74941aab67cc7e1925e3ded014969a28
http://hdl.handle.net/2066/153132
http://hdl.handle.net/2066/153132
Autor:
Johanna Berkhout, Rienk Nieuwland, Augueste Sturk, Fred P.H.T.M. Romijn, Karin Joop, C. Erik Hack, R.J. Berckmans
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Summary Aim. We investigated the occurrence and thrombin generating mechanisms of circulating microparticles (MP) in patients with multiple organ dysfunction syndrome (MODS) and sepsis. Methods. MP, isolated from blood of patients (n = 9) and healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac4a2f318ee5bee1384e8d710c9f2ff
http://europepmc.org/abstract/med/11372673
http://europepmc.org/abstract/med/11372673